Thiazole-phosphate synthase (ThiG) (ThiG)

Thiazole-phosphate synthase (ThiG) is a crucial enzyme in the de novo biosynthesis of thiamine (vitamin B1), specifically catalyzing the formation of the thiazole phosphate moiety (UniProt P0A877). This enzyme is found in a wide range of bacteria, fungi, and plants, but is absent in humans, who must obtain thiamine through their diet (Chemical Reviews, 2009). Because thiamine is an essential cofactor for enzymes involved in central metabolism, such as the pyruvate dehydrogenase complex, its synthesis is vital for the survival and pathogenesis of many microbes (Nature Communications, 2015). Consequently, thiazole-phosphate synthase is recognized as a promising target for the development of novel antimicrobial agents (Future Medicinal Chemistry, 2011). Inhibition of this enzyme leads to thiamine auxotrophy, effectively starving the pathogen of a necessary nutrient and halting its growth (Chemical Reviews, 2009). While no drugs targeting this enzyme are currently in clinical use, research is ongoing to identify small-molecule inhibitors that can selectively disrupt the complex sulfur-transfer mechanism required for thiazole formation (Nature Communications, 2015). Such inhibitors could provide a new class of antibiotics to combat multi-drug resistant infections (Future Medicinal Chemistry, 2011). The specificity of this target to non-human organisms minimizes the risk of direct host toxicity, although potential effects on the commensal gut microbiota remain a consideration for therapeutic development (UniProt P0A877).

Other names

Thiazole synthaseThiazole biosynthesis protein ThiGSulfur carrier protein ThiS-binding protein

Inhibition of the enzymatic synthesis of the thiazole phosphate precursor of thiamine, leading to metabolic arrest in pathogens.